Skip to main content
COGT logo

COGT · Cogent Biosciences, Inc. · Analyst Estimates

Track COGT — free
$26.72 -1.03 (-3.70%) At close · Nov 20
Market Cap
$4.65B
Shares
173.99M
Volume · Nov 20 2.13M Avg daily vol (3M) 2.08M

Analyst Estimates

Compare analyst forecasts for Cogent Biosciences, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-17 12:29 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.53
-2.33
-2.02
9
-2.22
-2.21
-2.21
-2.21
4
4
0
0
Revenue
USD
Publication date not stated
0.00
5.22M
13.80M
10
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.02
-1.27
-0.45
10
-1.28
-1.18
-1.11
-1.11
4
5
0
0
Revenue
USD
Publication date not stated
121.83M
279.78M
393.00M
10
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.72
-0.64
-0.52
9
-0.60
-0.58
-0.58
-0.58
4
4
0
0
Revenue
USD
Publication date not stated
0.00
5.22M
13.80M
10
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.56
-0.52
-0.49
4
-0.54
-0.52
-0.52
-0.51
2
2
0
0
Revenue
USD
Publication date not stated
7.20M
29.32M
41.00M
6
— — — — — — — —
Key facts CIK 1622229 CUSIP 19240Q201 13F (30d) 323 filings 300 filers Visit website Investor relations